The interferon regulatory factors and oncogenesis
Abstract
We study a family of transcription factors, the interferon regulatory factors (IRFs), as originally identified in the context of the regulation of type-I interferon (IFN-alpha/beta) system. Most notably, studies on IRF-1 have revealed its remarkable functional diversity in the regulation of cellular responses of host defense, including oncogenesis. The IRF family has now expanded to nine members, and gene disruption studies have revealed critical involvement of some of the members in the regulation of cell growth and oncogenesis. In this review, we summarize our current knowledge on the involvement of members of the IRF family members, in particular, IRF-1, in oncogenesis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IRF-2 has oncogenic potential.
“in light of well-known anti-oncogenic and proapoptotic functions of IRF1 and the oncogenic potential of IRF-2, (61)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [61]
ICSBP may regulate growth/apoptosis-related genes in myeloid cells by interacting with IRF-1 or IRF-2 or both.
“in light of well-known anti-oncogenic and proapoptotic functions of IRF1 and the oncogenic potential of IRF-2, (61) ICSBP may regulate growth/apoptosis-related genes in myeloid cells by interacting with IRF-1 or IRF-2 or both.”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [61]
IRF-1 has anti-oncogenic and proapoptotic functions.
“in light of well-known anti-oncogenic and proapoptotic functions of IRF1 and the oncogenic potential of IRF-2, (61)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [61]
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · see citing works
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,184 · see citing works
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · see citing works
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · see citing works
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271 · see citing works
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,718 · see citing works
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,490 · see citing works
Marié, I., Durbin, J. E., & Levy, D. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049 · see citing works
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 977 · see citing works
Self-citationHarada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957 · see citing works
Self-citationOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 952 · see citing works
Reversible tumorigenesis by MYC in hematopoietic lineages.
Felsher, D., & Bishop, J. (1999) · Molecules and Cells · doi:10.1016/s1097-2765(00)80367-6 · Cited by 917 · see citing works
Lin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915 · see citing works
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV
Moore, P. S., Boshoff, C., Weiss, R. A., & Chang, Y. (1996) · Science · doi:10.1126/science.274.5293.1739 · Cited by 900 · see citing works
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843 · see citing works
Self-citationWathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730 · see citing works
The Action of Oncogenes in the Cytoplasm and Nucleus
Weinberg, R. A. (1985) · Science · doi:10.1126/science.2997917 · Cited by 676 · see citing works
Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90201-1 · Cited by 665 · see citing works
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · see citing works
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 631 · see citing works
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583 · see citing works
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works
Positive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7
Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T., & Tanaka, N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01514-2 · Cited by 553 · see citing works
Self-citationHunter, T. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 552 · see citing works
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491 · see citing works
Self-citationThe growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2
Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., & Taniguchi, T. (1993) · Science · doi:10.1126/science.8438157 · Cited by 436 · see citing works
Self-citationAn IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431 · see citing works
Self-citationInterferons and other regulatory cytokines
Demaeyer, E. M., & Maeyer‐Guignard, J. D. (1988) · Medical Entomology and Zoology · Cited by 420 · see citing works
Tanaka, N., Kawakami, T., & Taniguchi, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4531 · Cited by 406 · see citing works
Self-citationStructure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397 · see citing works
Veals, S. A., Schindler, C., Leonard, D. G. B., Fu, X.-Y., Aebersold, R. H., Darnell, J. E., Jr., & Levy, D. E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3315 · Cited by 389 · see citing works
Deletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia
Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., et al. (1993) · Science · doi:10.1126/science.8438156 · Cited by 380 · see citing works
Self-citationHarada, H., Willison, K. R., Sakakibara, J., Miyamoto, M., Fujita, T., & Taniguchi, T. (1990) · Cell · doi:10.1016/0092-8674(90)90163-9 · Cited by 368 · see citing works
Self-citationAn IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366 · see citing works
Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1
Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L., & Taniguchi, T. (1989) · Nature · doi:10.1038/337270a0 · Cited by 358 · see citing works
Self-citationKSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
Gao, S., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., & Moore, P. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201571 · Cited by 356 · see citing works
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato, T., Yokochi, T., Waldmann, T. A., Taniguchi, T., & Taki, S. (1998) · Nature · doi:10.1038/35636 · Cited by 354 · see citing works
Self-citationMultistage Regulation of Th1-Type Immune Responses by the Transcription Factor IRF-1
Taki, S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Shin, E.-H., Kojima, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80443-4 · Cited by 353 · see citing works
Self-citationWeaver, B. K., Kumar, K. P., & Reich, N. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1359 · Cited by 351 · see citing works
Pine, R., Canova, A., & Schindler, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06245.x · Cited by 347 · see citing works
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Iida, S., Rao, P. H., Butler, M. P., Corradini, P., Boccadoro, M., Klein, B., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 335 · see citing works
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., & Taniguchi, T. (1996) · Nature · doi:10.1038/382816a0 · Cited by 324 · see citing works
Self-citationBERGHE, H. V. D., Vermaelen, K., Mecucci, C., Barbieri, D., & Tricot, G. J. K. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90016-0 · Cited by 322 · see citing works
Interferons and other regulatory cytokines
Meager, A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90301-3 · Cited by 313 · see citing works
Involvement of the IRF-1 Transcription Factor in Antiviral Responses to Interferons
Kimura, T., Nakayama, K., Penninger, J. M., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilček, J., Mak, T. W., et al. (1994) · Science · doi:10.1126/science.8009222 · Cited by 304 · see citing works
Self-citationHarada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T.-A., & Taniguchi, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1500 · Cited by 298 · see citing works
Self-citationFujita, T., Reis, L. F. L., Watanabe, N., Kimura, Y., Taniguchi, T., & Vilček, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9936 · Cited by 287 · see citing works
Self-citationHuman β-interferon gene expression is regulated by an inducible enhancer element
Goodbourn, S., Zinn, K., & Maniatis, T. (1985) · Cell · doi:10.1016/s0092-8674(85)80024-6 · Cited by 286 · see citing works
Interferon Regulatory Factor-1 Is Required for a T Helper 1 Immune Response In Vivo
Lohoff, M. D., Ferrick, D. A., Mittrücker, H., Duncan, G. S., Bischof, S., Röllinghoff, M., & Mak, T. W. (1997) · Immunity · doi:10.1016/s1074-7613(00)80444-6 · Cited by 286 · see citing works
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280 · see citing works
Sato, M., Tanaka, N., Hata, N., Oda, E., & Taniguchi, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00210-5 · Cited by 264 · see citing works
Self-citationMayeda, A., Helfman, D. M., & Krainer, A. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2993 · Cited by 242 · see citing works
Influence of sun exposures during childhood and during adulthood on melanoma risk
Autier, P., & Doré, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4 · Cited by 235 · see citing works
Self-citationMatsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 232 · see citing works
Self-citationOverlapping positive and negative regulatory domains of the human beta-interferon gene.
Goodbourn, S., & Maniatis, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1447 · Cited by 232 · see citing works
Expression of Gene rrg Is Associated with Reversion of NIH 3Tt3 Transformed by LTR-c-H- ras
Contente, S., Kenyon, K., Rimoldi, D., & Friedman, R. M. (1990) · Science · doi:10.1126/science.1697103 · Cited by 221 · see citing works
Lysyl Oxidase and rrg Messenger RNA
Kenyon, K., Contente, S., Trackman, P. C., Tang, J. H., Kagan, H. M., & Friedman, R. M. (1991) · Science · doi:10.1126/science.1678898 · Cited by 207 · see citing works
Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199 · see citing works
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works
Self-citationActivation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L., & Stein, G. S. (1995) · Nature · doi:10.1038/377362a0 · Cited by 189 · see citing works
Self-citationKondo, T., Minamino, N., Nagamura‐Inoue, T., Matsumoto, M., Taniguchi, T., & Tanaka, N. (1997) · Oncogene · doi:10.1038/sj.onc.1201286 · Cited by 177 · see citing works
Self-citationEklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176 · see citing works
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162 · see citing works
Abdollahi, A., Lord, K. A., Hoffman‐Liebermann, B., & Liebermann, D. A. (1991) · PubMed · Cited by 151 · see citing works
Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · see citing works
ISGF3γ p48, a specificity switch for interferon activated transcription factors
Bluyssen, H. A. R. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00005-6 · Cited by 135 · see citing works
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 127 · see citing works
IRF-1: the transcription factor linking the interferon response and oncogenesis
Taniguchi, T., Lamphier, M. S., & Tanaka, N. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00014-0 · Cited by 121 · see citing works
Self-citationNozawa, H., Oda, E., Nakao, K., Ishihara, M., Ueda, S., Yokochi, T., Ogasawara, K., Nakatsuru, Y., SHIMIZU, S., Ohira, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.10.1240 · Cited by 120 · see citing works
Self-citationHarada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hirai, H., & Taniguchi, T. (1994) · PubMed · Cited by 114 · see citing works
Self-citationNelson, N., Kanno, Y., Hong, C., Contursi, C., Fujita, T., Fowlkes, B. J., O’Connell, E., Hu-Li, J., Paul, W. E., Jankovic, D., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3711 · Cited by 110 · see citing works
Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y. A., Terashima, M., Saito, K., & Satodate, R. (1996) · PubMed · Cited by 105 · see citing works
Mouse models in tumor suppression
Ghebranious, N., & Donehower, L. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202573 · Cited by 103 · see citing works
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100 · see citing works
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV
Moore, P. S., & Chang, Y. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01408-5 · Cited by 98 · see citing works
Common deleted region on the long arm of chromosome 5 in esophageal carcinoma
Ogasawara, S., Tamura, G., Maesawa, C., Suzuki, Y. A., Ishida, K., Satoh, N., Uesugi, N., Saito, K., & Satodate, R. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536888 · Cited by 89 · see citing works
Harada, H., Takahashi, E., Itoh, S., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1500-1509.1994 · Cited by 89 · see citing works
Cell Cycle Regulation of Histone H4 Gene Transcription Requires the Oncogenic Factor IRF-2
Vaughan, P. S., van der Meijden, C. M. J., Aziz, F., Harada, H., Taniguchi, T., van Wijnen, A. J., Stein, J. L., & Stein, G. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.194 · Cited by 83 · see citing works
Self-citationTan, R. S., Taniguchi, T., & Harada, H. (1996) · PubMed · Cited by 83 · see citing works
Self-citationSuppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
Tanaka, N., Ishihara, M., & Taniguchi, T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90318-2 · Cited by 80 · see citing works
Self-citationMatikainen, S., Ronni, T., Lehtonen, A., Sareneva, T., Melén, K., Nordling, S., Levy, D. E., & Julkunen, I. (1997) · PubMed · Cited by 77 · see citing works
Boultwood, J., Fidler, C., Lewis, S. M., MacCarthy, A. B., Sheridan, H., Kelly, S., Oscier, D. G., Buckle, V., & Wainscoat, J. S. (1993) · Blood · doi:10.1182/blood.v82.9.2611.2611 · Cited by 60 · see citing works
Nguyen, H. T. T., Mustafa, A., Hiscott, J. B., & Lin, R. (1995) · PubMed · Cited by 51 · see citing works
Assignment of the human interferon regulatory factor-1 (IRF1) gene to chromosome 5q23–q31
Itoh, S., Harada, H., Nakamura, Y., White, R. L., & Taniguchi, T. (1991) · Genomics · doi:10.1016/0888-7543(91)90208-v · Cited by 44 · see citing works
Self-citationThe interferon-inducible murine p48 (ISGF3γ) gene is regulated by protooncogene c- myc
Weihua, X., Lindner, D. J., & Kalvakolanu, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7227 · Cited by 39 · see citing works
ICSAT Overexpression Is Not Sufficient to Cause Adult T-Cell Leukemia or Multiple Myeloma
Saito, T., Yamagata, T., Takahashi, T., Honda, H., & Hirai, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0911 · Cited by 17 · see citing works
(1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4458 · Cited by 10 · see citing works
Flagged first, then by citations
10 of the 101 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
IRF7: activation, regulation, modification and function
Ning, S., Pagano, J. S., & Barber, G. N. (2011) · Genes and Immunity · doi:10.1038/gene.2011.21 · Cited by 590 · see citing works
Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1
Zupkovitz, G., Tischler, J., Posch, M., Sadzak, I., Ramsauer, K., Egger, G., Grausenburger, R., Schweifer, N., Chiocca, S., Decker, T., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01220-06 · Cited by 262 · see citing works
Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice
Su, A. I., Guidotti, L. G., Pezacki, J. P., Chisari, F. V., & Schultz, P. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122359899 · Cited by 210 · see citing works
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · see citing works
Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.
Barnes, B. J., Kellum, M. J., Pinder, K. E., Frisancho, J. A., & Pitha, P. M. (2003) · PubMed · Cited by 175 · see citing works
IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2
Elser, B., Lohoff, M. D., Kock, S., Giaisi, M., Kirchhoff, S., Krammer, P. H., & Li‐Weber, M. (2002) · Immunity · doi:10.1016/s1074-7613(02)00471-5 · Cited by 172 · see citing works
Mancl, M. E., Hu, G., Sangster‐Guity, N., Olshalsky, S. L., Hoops, K. E. M., Fitzgerald-Bocarsly, P. A., Pitha, P. M., Pinder, K. E., & Barnes, B. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500543200 · Cited by 157 · see citing works
Crystal structure of PU. 1/IRF-4/DNA ternary complex
Escalante, C. R., Brass, A. L., Pongubala, J. M. R., Shatova, E., Shen, L., Singh, H., & Aggarwal, A. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00703-7 · Cited by 154 · see citing works
VSV-tumor selective replication and protein translation
Barber, G. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209042 · Cited by 147 · see citing works
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
Rezaee, S. A., Cunningham, C., Davison, A. J., & Blackbourn, D. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81919-0 · Cited by 144 · see citing works
ISG15: the immunological kin of ubiquitin
Ritchie, K. J., & Zhang, D. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.005 · Cited by 140 · see citing works
Tumor suppressor IRF‐1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
Clarke, N. M., Jimenez-Lara, A. M., Voltz, E., & Gronemeyer, H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600302 · Cited by 141 · see citing works
Reu, F. J., Bae, S. I., Cherkassky, L., Leaman, D. W., Lindner, D. J., Beaulieu, N., MacLeod, A. R., & Borden, E. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4074 · Cited by 125 · see citing works
AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges
Schauperl, M., & Denny, R. A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00026 · Cited by 122 · see citing works
ISG15: a ubiquitin-like enigma
Chinh, T.-T. (2005) · Frontiers in bioscience · doi:10.2741/1730 · Cited by 118 · see citing works
A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons
Asaoka, K., Ikeda, K., Hishinuma, T., Horie‐Inoue, K., Takeda, S., & Inoue, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.173 · Cited by 111 · see citing works
Review: Structure and Function of IRF-7
Zhang, L., & Pagano, J. S. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452700 · Cited by 109 · see citing works
Kim, P. K. M., Armstrong, M. J., Liu, Y., Yan, P., Bucher, B. T., Zuckerbraun, B. S., Gambotto, A. A., Billiar, T. R., & Yim, J. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207023 · Cited by 107 · see citing works
Fuld, S., Cunningham, C., Klucher, K. M., Davison, A. J., & Blackbourn, D. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3092-3097.2006 · Cited by 100 · see citing works
Wang, Y., Liu, D., Chen, P.-P., Koeffler, H. P., Tong, X.-J., & Xie, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3530 · Cited by 98 · see citing works
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Shao, L., Hou, W., Scharping, N. E., Vendetti, F. P., Srivastava, R., Roy, C. N., Menk, A. V., Wang, Y., Chauvin, J.-M., Karukonda, P., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0711 · Cited by 90 · see citing works
Lichty, B. D., Stojdl, D. F., Taylor, R. A., Miller, L., Frenkel, I., Atkins, H. L., & Bell, J. C. (2004) · Human Gene Therapy · doi:10.1089/1043034041839208 · Cited by 84 · see citing works
Gualco, G., Weiss, L. M., & Bacchi, C. E. (2010) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181cf1126 · Cited by 78 · see citing works
Lee, H., Cha, S.-H., Lee, M., Cho, G. J., Choi, W. S., & Suk, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5802 · Cited by 77 · see citing works
Martensen, P. M., & Justesen, J. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004772719864 · Cited by 73 · see citing works
D'Anello, L., Sansone, P., Storci, G., Mitrugno, V., D’Uva, G., Chieco, P., & Bonafè, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-300 · Cited by 67 · see citing works
Zhang, L., Zhang, J., Lambert, Q. T., Der, C. J., Valle, L. D., Judith Miklossy, A., Khalili, K., Zhou, Y., & Pagano, J. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12987-12995.2004 · Cited by 66 · see citing works
Li, Q., Tang, L., Roberts, P. C., Kraniak, J. M., Fridman, A. L., Kulaeva, O. I., Tehrani, O. S., & Tainsky, M. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0114 · Cited by 62 · see citing works
A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 60 · see citing works
Thuy, N. B. T., Ucisik-Akkaya, E., Davis, C. F., Morrison, B. A., & Dorak, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.015 · Cited by 60 · see citing works
Sers, C., Husmann, K., Nazarenko, I. A., Reich, S., Wiechen, K., Zhumabayeva, B., Adhikari, P., Schröder, K., Gontarewicz, A., & Schäfer, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205377 · Cited by 50 · see citing works
Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis
Chen, F., Jiang, G., Xu, K., & Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.1051 · Cited by 45 · see citing works
Pirini, F., Noazin, S., Jahuira-Arias, M. H., Rodríguez‐Torres, S., Friess, L., Michailidi, C., Cok, J., Combe, J., Vargas, G., Prado, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16258 · Cited by 44 · see citing works
Orlow, I., Satagopan, J. M., Berwick, M., Enriquez, H. L., White, K. A., Cheung, K., Dusza, S. W., Oliveria, S. A., Marchetti, M. A., Scope, A., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13467 · Cited by 41 · see citing works
A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15
Nakasato, N., Ikeda, K., Urano, T., Horie‐Inoue, K., Takeda, S., & Inoue, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.061 · Cited by 41 · see citing works
Interferon Regulatory Factor 4 (IRF-4) Targets IRF-5 to Regulate Epstein-Barr Virus Transformation
Xu, D., Meyer, F., Ehlers, E., Blasnitz, L., & Zhang, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210542 · Cited by 40 · see citing works
Review: Milstein Award Lecture: Interferons and Cancer: Where from Here?
Borden, E. C. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.511 · Cited by 40 · see citing works
Ortmann, C. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1001 · Cited by 40 · see citing works
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
Yi, J., Tavana, O., Li, H., Wang, D., Baer, R. J., & Gu, W. J. (2023) · Nature Communications · doi:10.1038/s41467-023-37617-3 · Cited by 41 · see citing works
Luo, X., & Ross, A. C. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100517 · Cited by 37 · see citing works
Hoshiya, Y., Gupta, V., Kawakubo, H., Brachtel, E. F., Carey, J., Sasur, L. M., Scott, A., Donahoe, P. K., & Maheswaran, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307626200 · Cited by 36 · see citing works
Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation
Zhang, L., & Pagano, J. S. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0411 · Cited by 35 · see citing works
Zeimet, A. G., Reimer, D., Wolf, D. G. F., Fiegl, H., Concin, N., Wiedemair, A., Wolf, A. M., Rumpold, H. F., Müller‐Holzner, E., & Marth, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24214 · Cited by 33 · see citing works
Nakamura, K., Shiozaki, A., Kosuga, T., Shimizu, H., Kudou, M., Ohashi, T., Arita, T., Konishi, H., Komatsu, S., Kubota, T., et al. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01212-6 · Cited by 29 · see citing works
Xia, W., Mruk, D. D., Lee, W. M., & Cheng, C. Y. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0158 · Cited by 29 · see citing works
Imaizumi, Y., Kohno, T., Yamada, Y., Ikeda, S., Tanaka, Y., Tomonaga, M., & Matsuyama, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02151.x · Cited by 29 · see citing works
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation
Massimino, M., Consoli, M. L., Mesuraca, M., Stagno, F., Tirrò, E., Stella, S., Pennisi, M. S., Romano, C., Buffa, P., Bond, H. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu013 · Cited by 27 · see citing works
Enhanced Expression of Interferon Regulatory Factor-1 in the Mucosa of Children with Celiac Disease
Salvati, V. M., MacDonald, T. T., Blanco, G. D. V., Mazzarella, G., Monteleone, I., Vavassori, P., Auricchio, S., Pallone, F., Troncone, R., & Monteleone, G. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000079184.70237.9c · Cited by 26 · see citing works
Matsumoto, M., Hisatake, K., Nogi, Y., & Tsujimoto, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104299200 · Cited by 24 · see citing works
Localization of IFN- γ -Activated Stat1 and IFN Regulatory Factors 1 and 2 in Breast Cancer Cells
Connett, J. M., Hunt, S. R., Hickerson, S. M., Wu, S. J., & Doherty, G. M. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003322558755 · Cited by 21 · see citing works
Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats
Samuelson, E., Hedberg, C., Nilsson, S., & Behboudi, A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0185 · Cited by 20 · see citing works
Qi, H., Zhu, H., Lou, M., Fan, Y., Liu, H., Shen, J., Li, Z., Lv, X., Shan, J., Zhu, L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313429 · Cited by 19 · see citing works
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
Sacchi, A., Giannessi, F., Sabatini, A., Percario, Z. A., & Affabris, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119353 · Cited by 18 · see citing works
Saito, H., Tada, S., Wakabayashi, K., Nakamoto, N., Takahashi, M., Nakamura, M., Ebinuma, H., & Ishii, H. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100196 · Cited by 17 · see citing works
Huang, B., Jia, Q. Q., Liang, Y., Huang, W. S., & Nie, P. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.08.003 · Cited by 16 · see citing works
Maratheftis, C. I., Giannouli, S., Spachidou, M. P., Panayotou, G., & Voulgarelis, M. (2007) · Neoplasia · doi:10.1593/neo.07640 · Cited by 16 · see citing works
Borden, E. C. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.022 · Cited by 15 · see citing works
Falcão, R. M., Kokaraki, G., Wispelaere, W. D., Amant, F. C., de Souza, G. A., de Souza, J. E. S., Carlson, J. W., & Lajus, T. B. P. (2022) · Cancers · doi:10.3390/cancers14205007 · Cited by 13 · see citing works
Mei, W., Yang, J., Tao, Q., Geng, X., Rupp, R. A. W., & Ding, X. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02688-6 · Cited by 13 · see citing works
IRF-1-binding site in the first intron mediates interferon-γ-induced optineurin promoter activation
Sudhakar, C., Vaibhava, V., & Swarup, G. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.065 · Cited by 11 · see citing works
Warrener, P., Kim, S., Williams, S. M. G., Biery, M. C., Gordon, M. L., Toniatti, C., Cleary, M. A., Linsley, P. S., & Carleton, M. O. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0707-4 · Cited by 10 · see citing works
Gira, A. K., Casper, K. A., Otto, K. B., Naik, S. M., Caughman, S. W., & Swerlick, R. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12535.x · Cited by 10 · see citing works
Xu, X., Zhang, H., Liu, Z. ‐., Wu, Q., Yang, P., Sun, S., Chen, J., Hsu, H., & Mountz, J. D. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01461.x · Cited by 8 · see citing works
Are There More Human Cancer Viruses Left to Be Found?
Moore, P. S., & Chang, Y. (2024) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-103721 · Cited by 8 · see citing works
Xu, D., Zhang, Y., Zhao, L., Cao, M., Lingel, A., & Zhang, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.005 · Cited by 8 · see citing works
Perazzio, A., de Oliveira, J. S. R., Figueiredo, V. L. D. P., & Chauffaille, M. D. L. L. F. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.008 · Cited by 7 · see citing works
IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation
Kawaguchi, M., Oka, T., Sugaya, M., Suga, H., Kimura, T., Morimura, S., Fujita, H., & Sato, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.12.014 · Cited by 7 · see citing works
Signal transduction by prolactin receptors
Yu‐Lee, L. (2002) · Neuroimmune biology · doi:10.1016/s1567-7443(02)80011-4 · Cited by 7 · see citing works
Bu, C., Wang, Z., Lv, X., & Zhao, Y. (2024) · Epigenetics · doi:10.1080/15592294.2024.2374988 · Cited by 6 · see citing works
Ma, Y., Ye, S., Liu, Y., Zhao, X., Wang, Y., & Wang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112988 · Cited by 6 · see citing works
Zhang, L., Wei, H., Yu, Y., Li, Q., Song, Z., Sun, Y., Li, P., Chen, J., Gan, J., Zhang, H., et al. (2023) · Aquaculture Reports · doi:10.1016/j.aqrep.2023.101672 · Cited by 6 · see citing works
Prolactin and Growth Hormone Receptors
Yu‐Lee, L., & Jeay, S. (2002) · Endocrine updates · doi:10.1007/978-1-4757-3600-7_7 · Cited by 6 · see citing works
Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance
Stewart, C. A., & Vivier, É. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_2 · Cited by 4 · see citing works
Ma, Z., Xu, C., Yang, R., Jing Hua, H. U., Zhou, S., & Yang, Q.-B. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.066 · Cited by 3 · see citing works
Interferons: Mechanisms, Biological Activities and Survey of their Use in Human Diseases
Obeid, D. A., & Bauvois, B. (2006) · Current Bioactive Compounds · doi:10.2174/157340706778992591 · Cited by 2 · see citing works
Molecular Pathology of Large Cell Carcinoma and Its Precursors
Eleazar, J. A., & Borczuk, A. (2008) · Molecular pathology library · doi:10.1007/978-0-387-72430-0_27 · Cited by 1 · see citing works
RBP-J dependent and independent signalling of EBNA-2
Grabušić, K. (2004) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.2168
Functional investigation of the class II tumor suppressor gene H-REV107-1
Nazarenko, I. A. (2003) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/14950
Large B-cell lymphoma with IRF4 rearrangement
Васильевна, П. Л., Моисеева, Т. Н., Al-Radi, L. S., Kovrigina, A. M., Обухова, Т. Н., Goryacheva, S. R., Shupletsova, I. A., Магомедова, А. У., & Kravchenko, S. K. (2021) · Гематология и трансфузиология · doi:10.35754/0234-5730-2021-66-3-445-457
Li, Q., Tang, L., Roberts, P. C., Kraniak, J. M., Fridman, A. L., Kulaeva, O. I., Tehrani, O. S., & Tainsky, M. A. (2023) · doi:10.1158/1541-7786.c.6542769.v1
Li, Q., Tang, L., Roberts, P. C., Kraniak, J. M., Fridman, A. L., Kulaeva, O. I., Tehrani, O. S., & Tainsky, M. A. (2023) · doi:10.1158/1541-7786.c.6542769
Qu, Y., Xu, N., Yao, Z., Zhang, L., Zhu, Y., Cai, T., Wang, Y., Li, K., Feng, J., Gu, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4008035/v1
Vilardo, L., Pelucchi, P., Brindisi, A., Abeni, E., Piscitelli, E., Mosca, E., Bertalot, G., Palizban, M., Karnavas, T., Gritzapis, A. D., et al. (2025) · Cells · doi:10.3390/cells14161246
Yuan, T., Liu, J., Zhu, R., Li, J., Zhiyong, H., Liang, H., Tao, H., & Zhang, E. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102600
T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunityPreprint
Shao, L., Banerjee, H., Ünal, E., Mehta, I., Das, J., Banday, A. R., Kane, L., & Sarkar, S. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.14.725206
- Authors
- Tanaka, N., & Taniguchi, T.
- Affiliations
- The University of Tokyo (JP)
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 10
- Issue
- 2
- Pages
- 73-81
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W1973282958
- Cited by
- 85
- References
- 101
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 2 · 2019: 2 · 2017: 3 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 3
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Cancer Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- interferon regulatory factors, IRF1, carcinogenesis, type I interferon, transcription factors, cell growth regulation, host defense, gene disruption
- MeSH terms
- DNA-Binding Proteins, Humans, Interferon Type I, Interferon-gamma, Neoplasms, Phosphoproteins, Transcription Factors, Interferon Regulatory Factor-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review